{"id":"W4400036644","doi":"10.1200/jco.2024.42.16_suppl.8577","title":"A phase II trial to evaluate the epithelial-to-mesenchymal (EMT) inhibitor sotevtamab combined with docetaxel in patients with metastatic non-small cell lung cancer following failure of primary chemoimmunotherapy.","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alethia Biotherapeutics (Canada); McGill University; Institute for Research in Immunology and Cancer; Institut universitaire de cardiologie et de pneumologie de Québec; Centre Intégré de Santé et de Services Sociaux des Laurentides; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Docetaxel; Chemoimmunotherapy; Oncology; Cancer; Internal medicine; Clinical trial; Phases of clinical research; Lung cancer; Chemotherapy; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001098279,0.00148143,0.002032622,0.0004372617,0.0003695762,0.0008230826,0.0008062365,0.001146307,0.003184819],"category_scores_gemma":[0.0006316888,0.0006131036,0.001112546,0.0004021172,0.0008358979,0.0005992774,0.0003271941,0.002084358,0.0008370632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00101205,"about_ca_system_score_gemma":0.001528944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001226898,"about_ca_topic_score_gemma":0.003514124,"domain_scores_codex":[0.99964,0.0001571891,0.00001668315,0.00006086033,0.00003112954,0.00009418533],"domain_scores_gemma":[0.9994196,0.00007101781,0.0001097544,0.00003867337,0.0000324506,0.0003285845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8156363,0.06223149,0.008838225,0.0007102665,0.0013432,0.0003288513,0.0002179722,0.001888436,0.03784038,0.0002358983,0.002938978,0.06779005],"study_design_scores_gemma":[0.4687853,0.513922,0.01152663,0.00002349556,0.0003887261,0.0002376836,0.00003781541,0.000867194,0.002345311,0.00008615851,0.0017614,0.00001835866],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994156,0.001412495,0.000321635,0.0002818952,0.000122803,0.001949909,0.0006598766,0.00006132554,0.001034003],"genre_scores_gemma":[0.9923028,0.001056852,0.0008037831,0.0004424639,0.0001738341,0.001811195,0.001573002,0.00001340733,0.001822683],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003184819,"threshold_uncertainty_score":0.01065433,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03577434989442194,"score_gpt":0.4337277492260453,"score_spread":0.3979533993316234,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}